Event Brief
Oct 23, 2026 at 9:13 PM ET
WHO announces Ebola vaccine trial in DR Congo
By The BriefBrief
The WHO announced the start of a clinical trial in the Democratic Republic of Congo to test the safety, efficacy and immunogenicity of multiple Ebola vaccines. Ervebo, approved against the more common Zaire strain, will be tested for possible cross-protection against the Bundibugyo strain.
WHO: The World Health Organization
WHAT: announced the start of a clinical trial of multiple Ebola vaccines in the Democratic Republic of Congo.
WHEN: Reported Oct 23, 2026 at 8:12 PM ET
WHERE: Democratic Republic of Congo
WHY: The trial is intended to test the vaccines’ safety, efficacy and immunogenicity, including whether Ervebo offers cross-protection against the Bundibugyo strain.
Reporting from 3 identified publishers across this event arc.
View all 3 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Navy and Marine Corps adopt ‘super intelligence’ term
U.s. Navy
Oct 23, 2026 at 9:07 PM ET
Rubio urges Cubans seeking change to partner with CIA
Marco Rubio
Oct 23, 2026 at 9:07 PM ET
Novatek secretly financed Alaska gas project, reports say
Novatek
Oct 23, 2026 at 9:00 PM ET
МВД взяло под контроль семь психоактивных веществ
Мвд
Oct 23, 2026 at 8:50 PM ET
